This healthcare stock engaged in providing comprehensive eye care services, including cataract surgeries and laser treatments across multiple locations globally, jumped 8 percent after the acquisition of a 1.14 percent stake in the company by Malabar India Fund.
Stock Price Movement:
With a market capitalization of Rs. 1,950.52 crores, the share of Dr Agarwals Eye Hospital Limited has reached an intraday high of Rs. 4,199 per equity share, rising nearly around 8.06 percent from its previous day’s close price of Rs. 3,885.85. Since then, the stock has retreated and is currently trading at Rs. 4,150.05 per equity share.
What Happened:
On March 3, 2025, Malabar India Fund purchased a 1.14 percent stake in Dr Agarwals Eye Hospital Limited at Rs 3,707 per share, which amounted to Rs 20.01 crore. Meanwhile, Kiftar In LLC sold a 0.89 percent stake in the company at the same price of Rs 3,707 per share, valuing the transaction at Rs 15.66 crore. Both deals were conducted in bulk, reflecting significant movements in the company’s shareholding.
Business operation:
Dr. Agarwal’s Eye Hospital operates over 180 centers in India and 15 centers abroad, including in Africa and other parts of Asia. The hospital offers a wide range of eye care services, such as cataract surgery, glaucoma treatment, laser correction, and more, ensuring comprehensive care for all types of eye conditions.
Recent Acquisitions:
Dr. Agarwal’s Eye Hospital has been expanding through acquisitions, including the purchase of five hospitals in Maharashtra in 2022. This expansion helps increase its reach and improve access to quality eye care across the region, further strengthening its position in the healthcare sector.
Recent quarter results:
Dr Agarwals Eye Hospital Limited’s revenue has increased from Rs. 76 crore in Q3 FY24 to Rs. 95 crore in Q3 FY25, which has grown by 25 percent. The net profit has also grown by 11.11 percent from Rs. 9 crore in Q3 FY24 to Rs. 10 crore in Q3 FY25.
Dr Agarwals Eye Hospital Limited’s revenue and net profit have grown at a CAGR of 13.41 percent and 30.83 percent, respectively, over the last five years.
In terms of return ratios, the company’s ROCE and ROE should be 18.4 percent and 34.4 percent, respectively. Dr Agarwals Eye Hospital Limited has an earnings per share (EPS) of Rs. 109, and its debt-to-equity ratio is 1.66x.
Written by – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
